Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT) Following Investor Meetings

June 4, 2020 8:13 AM EDT Send to a Friend
Cantor Fitzgerald analyst Steven Halper reiterated an Overweight rating and $44.00 price target on Health Catalyst Inc. (NASDAQ: HCAT) following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login